STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Celldex Therapeutics to Present at Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Celldex Therapeutics (NASDAQ:CLDX) has announced its management's participation in two upcoming investor conferences. The company will engage in fireside chats at the following events:

  • 2024 Cantor Global Healthcare Conference on Tuesday, September 17th at 8:35 a.m. ET
  • TD Cowen's Chronic Urticaria Summit on Friday, September 20th at 10:00 a.m. ET

Live webcasts of these presentations will be accessible on the 'Events & Presentations' page of the 'Investors & Media' section on Celldex's website. Replays will remain available for 90 days after each event, providing investors with extended access to the company's insights and updates.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

HAMPTON, N.J., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that management will participate in fireside chats at two upcoming conferences:

2024 Cantor Global Healthcare Conference on Tuesday, September 17th at 8:35 a.m. ET

TD Cowen's Chronic Urticaria Summit on Friday, September 20th at 10:00 a.m. ET

Live webcasts of the presentations will be available on the "Events & Presentations” page of the "Investors & Media" section of the Celldex website. Replays will be available for 90 days following the event.

About Celldex Therapeutics, Inc.
Celldex is a clinical stage biotechnology company leading the science at the intersection of mast cell biology and the development of transformative therapeutics for patients. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly affect critical pathways to improve the lives of patients with severe inflammatory, allergic, autoimmune and other devastating diseases. Visit www.celldex.com.

Company Contact
Sarah Cavanaugh
Senior Vice President, Corporate Affairs & Administration
(508) 864-8337
scavanaugh@celldex.com

Patrick Till
Meru Advisors
(484) 788-8560
ptill@meruadvisors.com


FAQ

When is Celldex Therapeutics (CLDX) presenting at the 2024 Cantor Global Healthcare Conference?

Celldex Therapeutics (CLDX) is presenting at the 2024 Cantor Global Healthcare Conference on Tuesday, September 17th at 8:35 a.m. ET.

What time is Celldex Therapeutics (CLDX) participating in TD Cowen's Chronic Urticaria Summit?

Celldex Therapeutics (CLDX) is participating in TD Cowen's Chronic Urticaria Summit on Friday, September 20th at 10:00 a.m. ET.

Where can investors watch the live webcasts of Celldex Therapeutics (CLDX) presentations?

Investors can watch the live webcasts of Celldex Therapeutics (CLDX) presentations on the 'Events & Presentations' page of the 'Investors & Media' section on the Celldex website.

How long will the replays of Celldex Therapeutics (CLDX) conference presentations be available?

Replays of Celldex Therapeutics (CLDX) conference presentations will be available for 90 days following each event.
Celldex Therapeutics Inc

NASDAQ:CLDX

CLDX Rankings

CLDX Latest News

CLDX Latest SEC Filings

CLDX Stock Data

1.72B
66.27M
0.19%
111.33%
10.86%
Biotechnology
In Vitro & in Vivo Diagnostic Substances
Link
United States
HAMPTON